USV Private Limited has announced new investment of Rs 400 crores a new state of art formulation plant at Vadodara, Gujarat. The project construction will start by Oct 2019 early,  The new unit will provide job opportunity to more than 350 people despite being a very highly automated plant. 

The company is leading healthcare company which began as a joint venture with USV&P Inc. USA, a subsidiary of Revlon. product offering today includes Active Pharmaceutical Ingredients (APIs), Fixed Dosages Formulations (FDF), Peptides, Biosimilars and Injectables. These are manufactured in our cGMP compliant plants located in India